ctivation of myocardial matrix metalloproteinase-1 (MMP-1) occurs within the region of acute myocardial infarction (AMI) in the pig, 1 and recently, Podesser et al reported that in the rat chronic post-myocardial infarction remodeling is associated with activation of MMPs (MMP-1, MMP-2, and MMP-9) in myocardium remote from the infarct. 2 MMP-1 is the only enzyme able to initiate degradation of collagen at neutral pH and Tyagi et al demonstrated that activation of MMP-1 in infarcted human myocardium might contribute to its remodeling, including ventricular dilatation and wall thinning. 3 The left ventricular ejection fraction (LVEF) predicts poor prognosis after AMI. 4,5 Sakuma et al showed left ventricular remodeling in patients with AMI using serial myocardial contrast echocardiography and magnetic resonance imaging, 6 and in the present study, we investigated whether there is a relationship between the concentration of serum MMP-1 and left ventricular remodeling after AMI.
Increased Serum Matrix Metalloproteinase-1 Concentration Predicts Advanced Left Ventricular Remodeling in Patients
With Acute Myocardial Infarction Hirofumi Soejima, MD; Hisao Ogawa, MD; Tomohiro Sakamoto, MD; Shinzo Miyamoto, MD; Ichiro Kajiwara, MD; Sunao Kojima, MD; Jun Hokamaki, MD; Seigo Sugiyama, MD; Michihiro Yoshimura, MD; Hisakazu Suefuji, MD*; Yuji Miyao, MD*; Kazuteru Fujimoto, MD*; Hiroo Miyagi, MD*; Hideki Kishikawa, MD** The left ventricular ejection fraction (LVEF) is one of the major prognostic factors after acute myocardial infarction (AMI) and matrix metalloproteinase-1 (MMP-1) is an enzyme responsible for extracellular collagen degradation and remodeling. The present study investigated whether the concentration of serum MMP-1 was associated with the LVEF after AMI. Blood was sampled on admission, and at 24 h, 3 days, 7 days, 2 weeks and 4 weeks in 24 patients with their first AMI. Left ventriculography was performed 4 weeks after the onset of AMI and the LVEF was calculated by center line method. MMP-1 concentrations were higher at 7 days and at 2 weeks than on admission (p<0.001), and at 7 days (r=-0.655, p=0.0005) and at 2 weeks (r=-0.636, p=0.0008) were negatively correlated with the LVEF. The patients with AMI were divided into high and low LVEF groups according to the results of left ventriculography. Although there were no differences in the clinical characteristics between the 2 LVEF groups, the MMP-1 concentrations at 24 h (p<0.01), 7 days (p<0.01) and 2 weeks (p<0.05) were lower in the high LVEF group than in low LVEF group. A high concentration of MMP-1 at the subacute phase after AMI predicts advanced left ventricular remodeling. In the all of the 22 patients with SEA, cardiac catheterization was performed 1 week after admission. All patients had major coronary arteries with at least 90% diameter stenosis. The number of diseased vessels in the 2 patient groups is shown in Table 1 .
Blood Sampling
An initial 5 ml aliquot of blood was drawn from an antecubital vein using a 21-gauge needle while the patient was recumbent. The samples were centrifuged at 3,000 rpm for 10 min and after centrifugation, the samples were immediately stored at -80°C until analysis of CK, CK-MB, and lipid concentrations and MMP-1 antigen assay. Venous blood samples from the patients with AMI were obtained on admission, 24 h, 3 days, 7 days, 2 weeks, and 4 weeks after admission, and those from the patients with SEA were obtained the morning after admission.
Serum MMP-1 Assay
A currently available enzyme immunoassay kit (MMP-1 Kit, Fuji Chemical Industries Ltd, Takaoka, Japan) 7 was used for the MMP-1 assay. It is based on the one-step sandwich method. The normal MMP-1 antigen concentration in the laboratory used for the assay (n=22) is 10.5±6.5 (mean ± SD) nmol/L. Intra-and interassay coefficients of variation were 8.4% and 10.4%, respectively.
Statistical Analyses
All data are expressed as mean ± SD. Comparisons of age and the concentrations of serum total cholesterol, serum high density lipoprotein cholesterol and serum triglycerides between the 2 patient groups were performed with unpaired t test. Serum MMP-1 concentrations over the time course were compared using one-way ANOVA for repeated measures. When the results were significant, the significance level for correlations is given after applying the Bonferroni method. 8 The frequency data of the 2 patient groups were compared by the chi squared test. Probability levels less than 0.05 were considered statistically significant. (Table 1) The AMI and SEA groups were matched for the extent of coronary artery disease and there were no significant differences in age, sex, concentrations of lipids, and the frequencies of diabetes mellitus, hypertension, smoking, and obesity between the 2 groups.
Results

Patient Characteristics
Assessment of Serum MMP-1 Antigen Concentration
The serum MMP-1 antigen concentrations (nmol/L) on admission were 23.4±8.0 in patients with AMI and 12.0± 7.7 in patients with SEA ( Fig 1) . Furthermore, concentrations in the AMI group increased from 23.4±8.0 on admission to 57.2±45.6 at 1 week and 64.9±62.5 at 2 weeks (Fig 2) , and were continuously higher in patients with AMI (23.4±8.0 on admission, 31.7±33.4 at 24 h, 36.7±34.4 at 3 days, 57.2±45.6 at 7 days, 64.9±62.5 at 2 weeks, 45.7±55.6 at 4 weeks) than in patients with SEA throughout the study protocol. 
Correlation Between MMP-1 Concentration and LVEF at 4 Weeks
The correlation coefficient between the MMP-1 concentration and LVEF was calculated over the time course in patients with AMI and there was a good correlation (r=-0.605, p=0.0017 at 24 h, r=-0.655, p=0.0005 at 7 days, r=-0.636, p=0.0008 at 2 weeks) at 4 weeks (Fig 3) . Therefore, we investigated the difference in the clinical characteristics of the patients with a good LVEF and those with a poor LVEF by dividing the patients with AMI into high LVEF (≥60 %) and low LVEF groups (<60 %), which were matched for the age, sex, coronary data, medications and acute phase intervention therapy (Table 2 ). Furthermore, the peak concentrations of CK and CK-MB tended to higher in the low LVEF group than in high LVEF group, but they were not significant. Alternatively, the MMP-1 concentrations at 24 h (p<0.05), at 7 days (p<0.05) and 2 weeks (p< 0.01) after admission were significantly lower in the high LVEF group than in the low LVEF group (Table 2) .
Discussion
The present study shows that the serum MMP-1 concentration was increased on admission in patients with AMI compared with those with SEA. The serum MMP-1 concentration increased thereafter, reaching a peak concentration around 14 days. It has been reported that the MMP-2 and MMP-9 concentrations were more elevated in patients with AMI on admission than in those with SEA, 9, 10 which our data also confirmed. The concentration reached a peak at 2 weeks in the present study and that of Hirohata et al. 11 Cleutjens et al showed increased MMP-1 activity in infarcted tissue, followed by increments of MMP-1 mRNA, by zymography in experimental infarction in rats. 12 MMP-1 is produced in peripheral blood mononuclear cells, 13 and tumor necrosis factor alpha (TNF-) and interleukin-1 (IL-1) are stimulators of MMP-1 at the transcriptional level. 14 Manicourt et al used northern blotting to investigate the proinflammatory cytokines in the infarct of rats after reperfusion following acute myocardial, and showed that both TNF-mRNA and IL-1 mRNA were increased in the infarct tissue, with peaks at 1-2 h after reperfusion and on day 7. 15 Increased serum TNF-concentrations have also been found in the early phase of human AMI. 16 These reports support the influence of cytokines on MMP that causes an increase of serum MMP-1 concentration in the early phase and which peaks at 1 or 2 weeks. Furthermore, those reports indicate that MMP-1 plays a role in the left ventricular remodeling after AMI. In the present study, the MMP-1 concentrations were higher at 7 days and at 2 weeks compared with admission and there was a negative correlation between the MMP-1 concentrations at 7 days and at 2 weeks and LVEF at 4 weeks. Therefore, we investigated the difference in the clinical characteristics of patients with a good LVEF and those with poor LVEF. The MMP-1 concentrations at 7 days (p<0.05) and 2 weeks (p<0.01) after admission were significantly lower in the high LVEF group than in the low LVEF group, which indicates that the MMP-1 concentrations at the subacute phase is associated with left ventricular remodeling. Tyagi et al demonstrated that activation of MMP-1 in the infarcted myocardium may contribute to remodeling that includes ventricular dilatation and wall thinning, 3 and LVEF has been negatively correlated with MMP-2 concentration in patients with dilated cardiomyopathy. 17 The present data also indicate that a high MMP-1 concentration at the subacute phase is associated with poor LVEF in the chronic phase in patients with AMI and is compatible with reports that administration of an MMP inhibitor improved left ventricular remodeling after AMI in rats and mice. 2, 18 The blood CK concentration rises because the accumulated CK from injured myocardial cells is carried out by myocardial infarction leak into blood, and it peaks approximately 24 h after the onset of AMI. In contrast, we guess that MMP-1 is expressed in the whole heart including the infarct lesion when the remodeling is progressing, so that it increases in the blood later than CK. We consider that MMP-1 is not expressed in the heart before AMI, and is expressed in connection with the remodeling after AMI, during which it appears in the blood and peaks over 1 week or more. Therefore, we conclude that a high MMP-1 concentration is a marker for advanced remodeling and poor LVEF in patients with AMI.
Study Limitations
We could not compare the MMP-1 concentration among the patients with equivalent CK concentrations because of the small study population, so further study in such patients is needed. MMP-1 forms a complex with the tissue inhibitor of metalloproteinase that is inactive and undetectable by the measurement technique we used. However, there is a possibility that MMP-1 is increased by a deficiency in metabolism.
In conclusion, a high MMP-1 concentration may reflect advanced myocardial remodeling in patients with AMI.
